Capture1_960_600_1622726060_original

Effects of Super Inductive Stimulation in Respiratory Physiotherapy

Evaluation of the effects of Super Inductive Stimulation in respiratory physiotherapy after SARS-CoV-2 infection

December 8th, 2021

Piotr Kesicki1(A,B,C,D), Igor Šwierkowski1(E,F), Ewa Jachi(E,F) 9 Krystyna Rastawska2,3(B,F), Jacek tuniewskii(A,F), Katarzyna Bogacz1,2(D,E,G), Jan Szczegielniak1,2(C,G) 'Politechnika Opolska / Opole University of Technology, Czech Republic.

Objective: The objective of the study was to assess the effectiveness of Super Inductive Stimulation in respiratory therapy in patients after SARS-CoV2 infection.

Material and methods: The study was carried out in the specialist hospital of the Ministry of the Interior and Administration in Glucholazy, in the pulmonary department. Fifteen men aged 35 to 63 and fifteen women aged 32 to 69 participated in the study. Each patient underwent ten sessions of Super Inductive Stimulation.

Results: The use of Super Inductive Stimulation resulted in the reduction of moderate cough, chest pain, shortness of breath, severe cough with phlegm/sputum, sweating, headache, nausea, diarrhoea, muscle pain, lack of appetite, problems with concentration, problems with thinking and sleeping, and fatigue.

Conclusions: Analysis of the results showed a positive effect of the applied therapy. Taking into account the answers given before and after rehabilitation, the condition of the respondents improved by 20.18%. The largest differences in the results were observed in the case of headache, diarrhoea, and sleeping problems, being 39.85%, 30.91% and 28.57%, respectively. The comparison of the study results showed that the patients' quality of life improved.

Capture3_960_600_1622726077_original

Introduction: Acute respiratory failure is a clinical condition can result from many factors: local infection, toxins, mechanical injuries, and inflammation. The body, based on homeostasis, triggers defence reactions that block further lung damage, but it often contributes to the progressive degradation of the organ. Along with the expanding damage to, among others, the lung endothelium, serious problems related to the hypoxia of other organs, in particular the heart and kid-neys, may arise. Thus, acute respiratory failure may lead to the patient's death despite proper treatment. The global SARS-CoV-2 coronavirus pandemic began in November 2019. The infection with the pathogen results in the development of COVID-19. The disease, in severe cases, may lead to the emergence and development of acute pulmonary failure, often resulting in the patient's death despite intensive clinical therapy.

In many cases, although the patients recovered, the virus, apart from the negative impact on the human body during the disease, also causes long-term damage after the infection. Symptoms that are most common in convalescents include fatigue, shortness of breath, cough, and chest pain. The above-mentioned complications made it necessary to urgently undertake professional respiratory rehabilitation, which would help the patients restore their health as much as possible. The pillar on which the rehabilitation of a patient after COVID-19 can be based is Super Inductive Stimulation, meeting the key goals of rehabilitation, such as improving lung ventilation, preventing their fibrosis, improving airway patency, improving blood and lymph circulation, reduction and disappearance of residual inflammation in the lungs.

Material and methods: The study aimed at confirming the effectiveness of Super Inductive Stimulation in respiratory therapy after SARS-CoV-2 infection was carried out at the specialist hospital of the Ministry of the Interior and Administration in Glucholazy in the pulmonary department. For the purposes of the study, a questionnaire was created, assessing 18 symptoms on a numerical scale from 0, which meant that the patient did not have a given symptom, to 5, where the patient had a significant problem with a given symptom.

The questionnaire was entered into the database twice under the names: "Difficulties in functioning A", filled in before the start of rehabilitation and "Difficulties in functio-ning B", filled in after its completion. Patients were assigned individual identification numbers through the hospital's internal system. This allowed for the reliable verification of the results and their comparison. Be-fore starting therapy and on the day of its completion, each patient was asked to complete medical records, which included the appropriate questionnaires.

Using the questionnaire twice allowed for the assessment of the effectiveness of Super Inductive Stimulation in respiratory therapy. Out of 1,500 patients entered into the database, convalescents with acute respira-tory failure and no comorbidities were selected. Fifteen men aged 35 to 63 and fifteen women aged 32 to 69 were selected. Each patient underwent ten sessions of Super In-ductive Stimulation. The procedures were performed from 10.08.2020 to 10.02.2021. A single treatment session took place once a day. Rehabilitation began with a circulation improvement protocol that involved perfor-ming the procedure on the dorsal side of the torso, on the left and on the right. Another protocol was used with the purpose of improving breathing. The first part of the protocol involved stimulating the diaphragm on the left and on the right, then the intercostal muscles from the posterior and lateral sides were stimulated. After completion of reha-bilitation, the results included in questionnaires A (before) and B (after), were compared. 

Covid-study-with-description-v2_1640857206_original

Difficulties in functioning

Cough

The arithmetic mean of symptom severity scores before and after treatment was 1.3 and 1.03, respectively. The use of Super Inductive Stimulation showed that the mean severity of symptoms was reduced by 20.77%. 

covid-study-graph1-v3_1640858466_original
covid-study-graph2-v3_1640858466_original

RESULTS

The use of Super Inductive Stimulation resulted in the reduction of moderate cough, chest pain, shortness of breath, severe cough with phlegm/sputum, sweating, headache, nausea, diarrhoea, muscle pain, lack of appetite, problems with concentration, problems with thinking and sleeping and fatigue.

CONCLUSION

The analysis of the results showed a positive effect of the applied therapy. Taking into account the answers given before and after rehabilitation, the condition of the respondents improved by 20.18%. 2. The largest differences in the results were observed for headache, diarrhoea and sleeping problems, being 39.85%, 30.91% and 28.57%, respectively. 3. The comparison of the study results showed that thc patients quality of life improved. 

Read the entire study here: Evaluation of the effects of Super Inductive Stimulation in respiratory physiotherapy after SARS-CoV-2 infection

Check the technology used here: BTLcares

Latest news

Not all products and indications may be licensed in your country. For more information, contact your local representative.

 

In the EU, the following products are registered under different names: 

Focused Shockwave (BTL-6000 FSWT), Radial Shockwave (BTL-6000 RSWT), Super Inductive System (BTL-6000 Super Inductive System), High Intensity Laser (BTL-6000 High Intensity Laser), TR-Therapy (BTL-6000 TR-Therapy), Spinal Decompression (BTL-6000 Traction and BTL Spinal Decompression), Cryotherapy (BTL Cryotherapy), HandsFree Sono ( (BTL-4000 Smart / Premium); Combined Units (BTL-4000 Smart / Premium), Electrotherapy with vacuum unit (BTL-4000 Premium + BTL-Vac II), Low-Level Laser Therapy (BTL-4000 Smart / Premium), Magnetotherapy (BTL-4000 Smart / Premium), Combined Units (BTL-4000 Smart / Premium), Diathermy (BTL-6000 Shortwave and BTL-6000 Microwave), CPMotion (BTL-CPMotion), Lymphatic Drainage (BTL-6000 Lymphastim), Couches (BTL-1100, BTL-1300, BTL-1500), Hydrotherapy (BTL-3000)